INSIGHTS ON FACILITY DESIGN
Covid-19 Impact On Bioprocessing: PART 3 Long-Term Changes Resulting From The Pandemic
Changes in the bio/pharmaceutical industry are being accelerated and catalyzed by the responses to the current Covid-19 pandemic. Although suppliers have proven themselves rather robust in their dealing with the pandemic, and business is continuing generally uninterrupted, there will be significant changes.
Re-imagining Vaccine Manufacturing To Address Global Health Challenges
In the last decade, biopharmaceutical industries have had to mobilize quickly in response to pandemics. Developing vaccines and manufacturing large doses in an emergency is often constrained by existing platforms and facility set ups. Vaccine manufacturing needs to evolve to tackle future global health challenges. Watch this webinar to learn more.
COVID-19 Impact On Bioprocessing: PART 1 Accelerating Trends
Because of the urgent demand for treatments, vaccines and assays, the pharmaceutical and biotech industries are experiencing disruptive, often chaotic, increased demands on resources.
Three Options To Viral Vector Manufacturing Capacity
A recent Virtual Think Tank focused on the challenges and trends influencing design considerations for viral vector manufacturing facilities, and how they can impact companies developing cell and gene therapies.
What You Need To Know Before Investing In A Bioprocessing Space
Selecting the bioreactor that is best for your process and the dedicated space you have available requires consideration of many important factors.
6 Misconceptions About Automating Cell Therapy Manufacturing
To help you move into a digitized world, here are six common misconceptions that can potentially hinder your ability to successfully execute an MES for cell therapy.
Never Too Early To Plan For Automation
Early platform design selections can greatly affect your future automation flexibility and ability to show compliance throughout regulatory reviews.
Standardization Is Key To Building A Successful Global Business Strategy
Standardized approaches to biomanufacturing can lower costs, improve outcomes and alter the landscape of the global pharmaceutical market.
The Insource Vs. Outsource Dilemma
Prior to making critical capacity decisions, a small biotech company completed an economic evaluation of manufacturing options to ensure it was selecting the best strategy for its manufacturing. Discover the critical elements of this analysis that may help to balance your assessment.
FACILITY DESIGN SOLUTIONS
As the biopharma industry identifies faster and more efficient ways to deliver drugs to patients, such as break-through and fast track designations for accelerated approval, these progresses create pressure on both large and small drug manufacturers. As development timelines shorten, decisions related to drug commercialization need to be taken earlier, when key results are not yet available. And deciding on the scale and type of facility to build without complete data can create substantial risks with costly consequences.
GE Life Sciences Overview - Cell Processing
Helping your cell therapies succeed through our reach and resources.
Genderless AseptiQuik® L Series Connectors
Genderless AseptiQuik® Large Format 3/4", 1" and 1½" sanitary Connectors enable quick and easy sterile connections, even in non-sterile environments. The easy-to-use genderless design simplifies system integration and minimizes the risk of operator error. The connector's robust construction provides enhanced user confidence and reliable performance without the need for clamps, fixtures or tube welders. Biopharmaceutical manufacturers benefit from a full range of interchangeable 3/4" to 1½" flow solutions for production environments with the quality and market availability they expect from the leader in single-use connection technology.
Transformations In Biomanufacturing
In biomanufacturing the only certainty is risk and the only constant is change. Technology is pushing new frontiers, new markets are opening up across the globe, and new competition is creating new levels of urgency—all under the ever more watchful eye of regulators.
Genderless AseptiQuik® L Series Connectors Datasheet
Genderless AseptiQuik® L Connectors enable quick and easy sterile connections, in large-volume, high-flow production environments. The largeformat, 3/4" and 1" genderless design simplifies system integration and minimizes the risk of operator error.